The global Monoamine Oxidase Inhibitor (MAOIs) market was valued at US$ 167 million in 2023 and is anticipated to reach US$ 280.8 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.

Monoamine Oxidase Inhibitor (MAOIs) Market

MAOIs are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are widely used as anti-depressants.

North American market for Monoamine Oxidase Inhibitor (MAOIs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Monoamine Oxidase Inhibitor (MAOIs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Monoamine Oxidase Inhibitor (MAOIs) include Novartis, Pfizer, Validus Pharmaceuticals LLC, Eli Lilly & Company, GlaxoSmithKline, Merck & Co and Concordia Pharms, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Monoamine Oxidase Inhibitor (MAOIs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoamine Oxidase Inhibitor (MAOIs).

Report Scope

The Monoamine Oxidase Inhibitor (MAOIs) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoamine Oxidase Inhibitor (MAOIs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoamine Oxidase Inhibitor (MAOIs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoamine Oxidase Inhibitor (MAOIs) Market Report

Report Metric	Details
Report Name	Monoamine Oxidase Inhibitor (MAOIs) Market
Accounted market size in 2023	US$ 167 million
Forecasted market size in 2030	US$ 280.8 million
CAGR	7.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Nonselective MAO-A/MAO-B inhibitors Selective MAO-A/MAO-B inhibitors
Segment by Application	Atypical Depression Treatment Parkinson's Disease Treatment Other Therapy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Pfizer, Validus Pharmaceuticals LLC, Eli Lilly & Company, GlaxoSmithKline, Merck & Co, Concordia Pharms
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoamine Oxidase Inhibitor (MAOIs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoamine Oxidase Inhibitor (MAOIs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Monoamine Oxidase Inhibitor (MAOIs) Market growing?

Ans: The Monoamine Oxidase Inhibitor (MAOIs) Market witnessing a CAGR of 7.2% during the forecast period 2024-2030.

What is the Monoamine Oxidase Inhibitor (MAOIs) Market size in 2030?

Ans: The Monoamine Oxidase Inhibitor (MAOIs) Market size in 2030 will be US$ 280.8 million.

Who are the main players in the Monoamine Oxidase Inhibitor (MAOIs) Market report?

Ans: The main players in the Monoamine Oxidase Inhibitor (MAOIs) Market are Novartis, Pfizer, Validus Pharmaceuticals LLC, Eli Lilly & Company, GlaxoSmithKline, Merck & Co, Concordia Pharms

What are the Application segmentation covered in the Monoamine Oxidase Inhibitor (MAOIs) Market report?

Ans: The Applications covered in the Monoamine Oxidase Inhibitor (MAOIs) Market report are Atypical Depression Treatment, Parkinson's Disease Treatment, Other Therapy

What are the Type segmentation covered in the Monoamine Oxidase Inhibitor (MAOIs) Market report?

Ans: The Types covered in the Monoamine Oxidase Inhibitor (MAOIs) Market report are Nonselective MAO-A/MAO-B inhibitors, Selective MAO-A/MAO-B inhibitors

1 Monoamine Oxidase Inhibitor (MAOIs) Market Overview

1.1 Product Overview and Scope of Monoamine Oxidase Inhibitor (MAOIs)

1.2 Monoamine Oxidase Inhibitor (MAOIs) Segment by Type

1.2.1 Global Monoamine Oxidase Inhibitor (MAOIs) Market Value Comparison by Type (2024-2030)

1.2.2 Nonselective MAO-A/MAO-B inhibitors

1.2.3 Selective MAO-A/MAO-B inhibitors

1.3 Monoamine Oxidase Inhibitor (MAOIs) Segment by Application

1.3.1 Global Monoamine Oxidase Inhibitor (MAOIs) Market Value by Application: (2024-2030)

1.3.2 Atypical Depression Treatment

1.3.3 Parkinson's Disease Treatment

1.3.4 Other Therapy

1.4 Global Monoamine Oxidase Inhibitor (MAOIs) Market Size Estimates and Forecasts

1.4.1 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue 2019-2030

1.4.2 Global Monoamine Oxidase Inhibitor (MAOIs) Sales 2019-2030

1.4.3 Global Monoamine Oxidase Inhibitor (MAOIs) Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Monoamine Oxidase Inhibitor (MAOIs) Market Competition by Manufacturers

2.1 Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Manufacturers (2019-2024)

2.2 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Monoamine Oxidase Inhibitor (MAOIs) Average Price by Manufacturers (2019-2024)

2.4 Global Monoamine Oxidase Inhibitor (MAOIs) Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Monoamine Oxidase Inhibitor (MAOIs), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Monoamine Oxidase Inhibitor (MAOIs), Product Type & Application

2.7 Monoamine Oxidase Inhibitor (MAOIs) Market Competitive Situation and Trends

2.7.1 Monoamine Oxidase Inhibitor (MAOIs) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Monoamine Oxidase Inhibitor (MAOIs) Players Market Share by Revenue

2.7.3 Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Monoamine Oxidase Inhibitor (MAOIs) Retrospective Market Scenario by Region

3.1 Global Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Monoamine Oxidase Inhibitor (MAOIs) Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Region: 2019-2030

3.2.1 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Region: 2019-2024

3.2.2 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Region: 2025-2030

3.3 Global Monoamine Oxidase Inhibitor (MAOIs) Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region: 2019-2030

3.3.1 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region: 2019-2024

3.3.2 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region: 2025-2030

3.4 North America Monoamine Oxidase Inhibitor (MAOIs) Market Facts & Figures by Country

3.4.1 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2030)

3.4.3 North America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Facts & Figures by Country

3.5.1 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2030)

3.5.3 Europe Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Facts & Figures by Country

3.6.1 Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2030)

3.6.3 Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Facts & Figures by Country

3.7.1 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2030)

3.7.3 Latin America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Monoamine Oxidase Inhibitor (MAOIs) Market Facts & Figures by Country

3.8.1 Middle East and Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2030)

3.8.3 Middle East and Africa Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Type (2019-2030)

4.1.1 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Type (2019-2024)

4.1.2 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Type (2025-2030)

4.1.3 Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Type (2019-2030)

4.2 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Type (2019-2030)

4.2.1 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Type (2019-2024)

4.2.2 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Type (2025-2030)

4.2.3 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Type (2019-2030)

4.3 Global Monoamine Oxidase Inhibitor (MAOIs) Price by Type (2019-2030)

5 Segment by Application

5.1 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Application (2019-2030)

5.1.1 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Application (2019-2024)

5.1.2 Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Application (2025-2030)

5.1.3 Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Application (2019-2030)

5.2 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Application (2019-2030)

5.2.1 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Application (2019-2024)

5.2.2 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Application (2025-2030)

5.2.3 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Application (2019-2030)

5.3 Global Monoamine Oxidase Inhibitor (MAOIs) Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Corporation Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Monoamine Oxidase Inhibitor (MAOIs) Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novartis Monoamine Oxidase Inhibitor (MAOIs) Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Monoamine Oxidase Inhibitor (MAOIs) Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Monoamine Oxidase Inhibitor (MAOIs) Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Validus Pharmaceuticals LLC

6.3.1 Validus Pharmaceuticals LLC Corporation Information

6.3.2 Validus Pharmaceuticals LLC Description and Business Overview

6.3.3 Validus Pharmaceuticals LLC Monoamine Oxidase Inhibitor (MAOIs) Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Validus Pharmaceuticals LLC Monoamine Oxidase Inhibitor (MAOIs) Product Portfolio

6.3.5 Validus Pharmaceuticals LLC Recent Developments/Updates

6.4 Eli Lilly & Company

6.4.1 Eli Lilly & Company Corporation Information

6.4.2 Eli Lilly & Company Description and Business Overview

6.4.3 Eli Lilly & Company Monoamine Oxidase Inhibitor (MAOIs) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Eli Lilly & Company Monoamine Oxidase Inhibitor (MAOIs) Product Portfolio

6.4.5 Eli Lilly & Company Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Monoamine Oxidase Inhibitor (MAOIs) Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Monoamine Oxidase Inhibitor (MAOIs) Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Merck & Co

6.6.1 Merck & Co Corporation Information

6.6.2 Merck & Co Description and Business Overview

6.6.3 Merck & Co Monoamine Oxidase Inhibitor (MAOIs) Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Merck & Co Monoamine Oxidase Inhibitor (MAOIs) Product Portfolio

6.6.5 Merck & Co Recent Developments/Updates

6.7 Concordia Pharms

6.6.1 Concordia Pharms Corporation Information

6.6.2 Concordia Pharms Description and Business Overview

6.6.3 Concordia Pharms Monoamine Oxidase Inhibitor (MAOIs) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Concordia Pharms Monoamine Oxidase Inhibitor (MAOIs) Product Portfolio

6.7.5 Concordia Pharms Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Monoamine Oxidase Inhibitor (MAOIs) Industry Chain Analysis

7.2 Monoamine Oxidase Inhibitor (MAOIs) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Monoamine Oxidase Inhibitor (MAOIs) Production Mode & Process

7.4 Monoamine Oxidase Inhibitor (MAOIs) Sales and Marketing

7.4.1 Monoamine Oxidase Inhibitor (MAOIs) Sales Channels

7.4.2 Monoamine Oxidase Inhibitor (MAOIs) Distributors

7.5 Monoamine Oxidase Inhibitor (MAOIs) Customers

8 Monoamine Oxidase Inhibitor (MAOIs) Market Dynamics

8.1 Monoamine Oxidase Inhibitor (MAOIs) Industry Trends

8.2 Monoamine Oxidase Inhibitor (MAOIs) Market Drivers

8.3 Monoamine Oxidase Inhibitor (MAOIs) Market Challenges

8.4 Monoamine Oxidase Inhibitor (MAOIs) Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis

Pfizer Inc

Validus Pharmaceuticals LLC

List of Tables

Table 1. Global Monoamine Oxidase Inhibitor (MAOIs) Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Monoamine Oxidase Inhibitor (MAOIs) Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Monoamine Oxidase Inhibitor (MAOIs) Market Competitive Situation by Manufacturers in 2023

Table 4. Global Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg) of Key Manufacturers (2019-2024)

Table 5. Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Monoamine Oxidase Inhibitor (MAOIs) Average Price (US$/g) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Monoamine Oxidase Inhibitor (MAOIs), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Monoamine Oxidase Inhibitor (MAOIs), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Monoamine Oxidase Inhibitor (MAOIs), Product Type & Application

Table 12. Global Key Manufacturers of Monoamine Oxidase Inhibitor (MAOIs), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Monoamine Oxidase Inhibitor (MAOIs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoamine Oxidase Inhibitor (MAOIs) as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Region (2019-2024) & (Kg)

Table 18. Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Region (2019-2024)

Table 19. Global Monoamine Oxidase Inhibitor (MAOIs) Sales by Region (2025-2030) & (Kg)

Table 20. Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Region (2025-2030)

Table 21. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Region (2019-2024)

Table 23. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Region (2025-2030)

Table 25. North America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2024) & (Kg)

Table 27. North America Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2025-2030) & (Kg)

Table 28. North America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2024) & (Kg)

Table 32. Europe Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2025-2030) & (Kg)

Table 33. Europe Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Sales by Region (2019-2024) & (Kg)

Table 37. Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Sales by Region (2025-2030) & (Kg)

Table 38. Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2024) & (Kg)

Table 42. Latin America Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2025-2030) & (Kg)

Table 43. Latin America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2019-2024) & (Kg)

Table 47. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Sales by Country (2025-2030) & (Kg)

Table 48. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg) by Type (2019-2024)

Table 51. Global Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg) by Type (2025-2030)

Table 52. Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Type (2019-2024)

Table 53. Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Type (2025-2030)

Table 54. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Type (2019-2024)

Table 57. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Type (2025-2030)

Table 58. Global Monoamine Oxidase Inhibitor (MAOIs) Price (US$/g) by Type (2019-2024)

Table 59. Global Monoamine Oxidase Inhibitor (MAOIs) Price (US$/g) by Type (2025-2030)

Table 60. Global Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg) by Application (2019-2024)

Table 61. Global Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg) by Application (2025-2030)

Table 62. Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Application (2019-2024)

Table 63. Global Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Application (2025-2030)

Table 64. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Application (2019-2024)

Table 67. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Application (2025-2030)

Table 68. Global Monoamine Oxidase Inhibitor (MAOIs) Price (US$/g) by Application (2019-2024)

Table 69. Global Monoamine Oxidase Inhibitor (MAOIs) Price (US$/g) by Application (2025-2030)

Table 70. Novartis Corporation Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 73. Novartis Monoamine Oxidase Inhibitor (MAOIs) Product

Table 74. Novartis Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 78. Pfizer Monoamine Oxidase Inhibitor (MAOIs) Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Validus Pharmaceuticals LLC Corporation Information

Table 81. Validus Pharmaceuticals LLC Description and Business Overview

Table 82. Validus Pharmaceuticals LLC Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 83. Validus Pharmaceuticals LLC Monoamine Oxidase Inhibitor (MAOIs) Product

Table 84. Validus Pharmaceuticals LLC Recent Developments/Updates

Table 85. Eli Lilly & Company Corporation Information

Table 86. Eli Lilly & Company Description and Business Overview

Table 87. Eli Lilly & Company Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 88. Eli Lilly & Company Monoamine Oxidase Inhibitor (MAOIs) Product

Table 89. Eli Lilly & Company Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Monoamine Oxidase Inhibitor (MAOIs) Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Merck & Co Corporation Information

Table 96. Merck & Co Description and Business Overview

Table 97. Merck & Co Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 98. Merck & Co Monoamine Oxidase Inhibitor (MAOIs) Product

Table 99. Merck & Co Recent Developments/Updates

Table 100. Concordia Pharms Corporation Information

Table 101. Concordia Pharms Description and Business Overview

Table 102. Concordia Pharms Monoamine Oxidase Inhibitor (MAOIs) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 103. Concordia Pharms Monoamine Oxidase Inhibitor (MAOIs) Product

Table 104. Concordia Pharms Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Monoamine Oxidase Inhibitor (MAOIs) Distributors List

Table 108. Monoamine Oxidase Inhibitor (MAOIs) Customers List

Table 109. Monoamine Oxidase Inhibitor (MAOIs) Market Trends

Table 110. Monoamine Oxidase Inhibitor (MAOIs) Market Drivers

Table 111. Monoamine Oxidase Inhibitor (MAOIs) Market Challenges

Table 112. Monoamine Oxidase Inhibitor (MAOIs) Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Monoamine Oxidase Inhibitor (MAOIs)

Figure 2. Global Monoamine Oxidase Inhibitor (MAOIs) Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Type in 2023 & 2030

Figure 4. Nonselective MAO-A/MAO-B inhibitors Product Picture

Figure 5. Selective MAO-A/MAO-B inhibitors Product Picture

Figure 6. Global Monoamine Oxidase Inhibitor (MAOIs) Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application in 2023 & 2030

Figure 8. Atypical Depression Treatment

Figure 9. Parkinson's Disease Treatment

Figure 10. Other Therapy

Figure 11. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size (2019-2030) & (US$ Million)

Figure 13. Global Monoamine Oxidase Inhibitor (MAOIs) Sales (2019-2030) & (Kg)

Figure 14. Global Monoamine Oxidase Inhibitor (MAOIs) Average Price (US$/g) & (2019-2030)

Figure 15. Monoamine Oxidase Inhibitor (MAOIs) Report Years Considered

Figure 16. Monoamine Oxidase Inhibitor (MAOIs) Sales Share by Manufacturers in 2023

Figure 17. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Monoamine Oxidase Inhibitor (MAOIs) Players: Market Share by Revenue in 2023

Figure 19. Monoamine Oxidase Inhibitor (MAOIs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Country (2019-2030)

Figure 22. North America Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Country (2019-2030)

Figure 26. Europe Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Country (2019-2030)

Figure 27. Germany Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Region (2019-2030)

Figure 34. China Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Country (2019-2030)

Figure 45. Latin America Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Monoamine Oxidase Inhibitor (MAOIs) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Monoamine Oxidase Inhibitor (MAOIs) by Type (2019-2030)

Figure 55. Global Revenue Market Share of Monoamine Oxidase Inhibitor (MAOIs) by Type (2019-2030)

Figure 56. Global Monoamine Oxidase Inhibitor (MAOIs) Price (US$/g) by Type (2019-2030)

Figure 57. Global Sales Market Share of Monoamine Oxidase Inhibitor (MAOIs) by Application (2019-2030)

Figure 58. Global Revenue Market Share of Monoamine Oxidase Inhibitor (MAOIs) by Application (2019-2030)

Figure 59. Global Monoamine Oxidase Inhibitor (MAOIs) Price (US$/g) by Application (2019-2030)

Figure 60. Monoamine Oxidase Inhibitor (MAOIs) Value Chain

Figure 61. Monoamine Oxidase Inhibitor (MAOIs) Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions